# Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

> **NCT00004858** · PHASE1 · UNKNOWN · sponsor: **Parker Hughes Cancer Center**

## Conditions studied

- Leukemia
- Lymphoma

## Interventions

- **BIOLOGICAL:** B43-genistein immunoconjugate

## Key facts

- **NCT ID:** NCT00004858
- **Lead sponsor:** Parker Hughes Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004858, "Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00004858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*